I can understand holders being miffed with the share price.But...

I can understand holders being miffed with the share price.

But CHM is a very risky play. The risk isn't the pipeline but the financial pathway. This is a bit different from what we normally see on the ASX.

The market cap has no value for the pipeline at the moment. This helps mitigate some of the dilution risk.

For any holder to be able to realise the potential gain, CHM needs to keep that pipeline progressing. To keep it progressing, it needs money. As posters above have pointed out, the pipeline is showing lots of promise.

This certainly isn't an investment for everybody. But the potential upside is huge. The potential downside is total loss. Another binary outcome.

So sometimes you have to do the "dirty harry" and ask yourself if "you feel lucky?". (Hopefully, some oldies will get that).

I am looking forward for this placement being done and dusted. I am hopeful for more positive updates on the Cd17 drug. And am hopeful that the options which will be inbound shortly are in the money well before expiry.